| Category: | Health, |
|---|---|
| Address: | 3300 Hyland Ave, Costa Mesa, CA 92626, USA |
| Postal code: | 92626 |
| Phone: | (657) 859-2000 |
| Website: | https://www.celgene.com/ |
There are no reviews yet!
You can review this Business and help others by leaving a comment. If you want to share your thoughts about Celgene Corporation, use the form below and your opinion, advice or comment will appear in this space.
Celgene Corporation is a pharmaceutical company that makes cancer and immunology drugs. Its major product is Revlimid (lenalidomide), which is used in the treatment of multiple myeloma, and also in certain anemias.
Hier finden Sie Kontaktinformationen für Celgene Corporation und Celgene International . Besuchen Sie medizinische Informationen 24 Stunden am Tag , sieben Tage die Woche . Nutzen Sie unser Kontakt Formular aus, um eine E-Mail Ihre Mitteilung an Celgene.
Celgene Ltd does not endorse and/or influence the content found on this website, including those from Celgene Corporation (U.S.) and other Celgene country affiliates. You are solely responsible for your interactions with this website.
Find out what works well at Celgene Corporation from the people who know best. Get the inside scoop on jobs, salaries, top office locations, and CEO insights. Compare pay for popular roles and read about the team's work-life balance. Uncover why Celgene Corporation is the best company for you.
Celgene Corporation is a biopharmaceutical company focused on developing and marketing therapies to treat leprosy, cancer, and immunological diseases. The company's technology centers on using small molecules to prevent tumors from forming blood vessels and regulating the pathways of cellular...
Celgene Corporation (NASDAQ: CELG) stock closed at 108.24 per share at the end of the most recent trading day (a 0.1% change compared to the prior day closing price) with a volume of 191.23M shares and market capitalization of 77.04B. Is a component of indices and it is traded on NASDAQ exchange.
Celgene Corporation (NASDAQ: CELG) reported operating results for the fourth quarter and full year of 2018. For the fourth quarter of 2018, net product sales were $4,036 million, an increase of 16 percent year-over-year.
Celgene Corporation is a global biopharmaceutical company. The Company focuses on the discovery, development, and commercialization of therapies designed to treat cancer and immune-inflammatory related diseases.
Celgene Corporation is a global integrated biopharmaceutical company primarily engaged in the discovery, development and commercialization of innovative therapies designed to treat cancer and immune-inflammatory related diseases in patients with limited treatment options.
Free and open company data on Delaware (US) company CELGENE CORPORATION (company number 2088605). CELGENE CORPORATION. Company Number. 2088605.